USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
RXBIO, INC.
Address:
1325 SUNSET DR
JOHNSON CITY, TN 37604-3619
Phone:
N/A
URL:
N/A
EIN:
194342545
DUNS:
185698334
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $391,936.00 3

Award List:

LPA Receptor Modulators as Radioprotectants

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$97,162.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The goal of this Phase I proposal is to perform lead optimization of a novel small molecular radioprotectant based on the Rx100 scaffold. Rx100, a metabolically stabilized analog of phospholipid growth factor lysophosph atidic acid (LPA), has shown promising… More

Development of an LPA receptor modulator Rx100 as a radioprotectant

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$99,977.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Bone marrow and gastrointestinal mucosa are highly sensitive to radiation exposure. Radiation-induced damage to bone marrow and the gastrointestinal tract could be lethal in events such as nuclear accidents or radiation terrorism, depending on radiation doses,… More

TAS::75 0849::TAS

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$194,797.00
Agency:
HHS
Principal Investigator:
Wenlin Deng – 423-928-3330
Abstract:
No satisfactory medical interventions for radiation enteritis are available yet. We have demonstrated that polyamine inhibition by a-difluoromethylornithine orDFMO, a selective and irreversible inhibitor of ornithine decarboxylase (ODC, the primary rate-limiting enzyme in the production of… More